NYLIM
MRTX

New York Life Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

New York Life Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-255,584
Closed -$15M – 1580
2023
Q4 		$15M Buy
+255,584
New +$15M 0.15% 128